Adaptimmune Therapeutics PLC Quarterly Return On Assets in % from Q4 2016 to Q4 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Adaptimmune Therapeutics PLC quarterly/annual Return On Assets history and growth rate from Q4 2016 to Q4 2024.
  • Adaptimmune Therapeutics PLC Return On Assets for the quarter ending December 31, 2024 was -24.8 %, a 34.1% increase year-over-year.
  • Adaptimmune Therapeutics PLC annual Return On Assets for 2024 was -24.8 %, a 34.1% increase from 2023.
  • Adaptimmune Therapeutics PLC annual Return On Assets for 2023 was -37.6 %, a 16.5% increase from 2022.
  • Adaptimmune Therapeutics PLC annual Return On Assets for 2022 was -45.1 %, a 15.7% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -24.8 +12.9 +34.1% Oct 1, 2024 Dec 31, 2024
Q3 2024 -15.1 +15.2 +50.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -25 +3.15 +11.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -55.4 -21.2 -62.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -37.6 +7.41 +16.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -30.3 +13.2 +30.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -28.2 +15 +34.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -34.1 +7.65 +18.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -45.1 -6.12 -15.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -43.5 -4.68 -12.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -43.2 -8.78 -25.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -41.8 -11.7 -38.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -38.9 -8.81 -29.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -38.8 -5.11 -15.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -34.4 +8.3 +19.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -30.1 +30.2 +50% Jan 1, 2021 Mar 31, 2021
Q4 2020 -30.1 +30.9 +50.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -33.7 +24.2 +41.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 -42.7 -6.41 -17.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -60.3 -22.1 -57.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -61 -24.4 -66.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -57.9 -24.9 -75.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 -36.3 -0.65 -1.82% Apr 1, 2019 Jun 30, 2019
Q1 2019 -38.3 -13.5 -54.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -36.6 -11.8 -47.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -33 -11.6 -53.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -35.6 -5.49 -18.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -24.8 +7.51 +23.2% Jan 1, 2018 Mar 31, 2018
Q4 2017 -24.8 +5.11 +17.1% Oct 1, 2017 Dec 31, 2017
Q3 2017 -21.5 Jul 1, 2017 Sep 30, 2017
Q2 2017 -30.1 Apr 1, 2017 Jun 30, 2017
Q1 2017 -32.3 Jan 1, 2017 Mar 31, 2017
Q4 2016 -29.9 Oct 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.